Abusief, M.E., M.D. Hornstein, and T. Jain. 2007. Assessment of United States fertility clinic websites according to the American Society for Reproductive Medicine (ASRM) Society for Assisted Reproductive Technology (SART) guidelines. Fertility and Sterility 87(1): 88–92.
Adamson, G.D., J. Mouzon, G.M. Chambers, et al. 2018. International Committee for Monitoring Assisted Reproductive Technology: World report on assisted reproductive technology, 2011. Fertility and Sterility 110(6): 1067–1080.
Agarwal, A., L.C. Sayres, M.K. Cho, R. Cook-Deegan, and S. Chandrasekharan. 2013. Commercial landscape of noninvasive prenatal testing in the United States. Prenatal Diagnosis 33(6): 521–531.
Article PubMed PubMed Central Google Scholar
Aleyamma, T.K., M.S. Kamath, K. Muthukumar, A.M. Mangalaraj, and K. George. 2011. Affordable ART: A different perspective. Human Reproduction 26(12): 3312–3318.
Article CAS PubMed Google Scholar
Alichniewicz, A., and M. Michalowska. 2015. Challenges to ART market: A Polish case. Medicine Health Care and Philosophy 18: 141–146.
Almeling, R. 2009. Gender and the value of bodily goods: Commodification in egg and sperm donation. Law and Contemporary Problems 72(3): 37–58.
Alon, I., J. Guimon, and R. Urbanos-Garrido. 2019. Regulatory responses to assisted reproductive technology: A comparative analysis of Spain and Israel. Journal of Assisted Reproduction & Genetics 36(8): 1665–1681.
Arksey, H., and L. O’Malley. 2005. Scoping studies: Towards a methodological framework. International Journal of Social Research Methodology 8(1): 19–32.
Armstrong, S., A. Vail, S. Mastenbroek, V. Jordan, and C. Farquhar. 2015. Time-lapse in the IVF-lab: How should we assess potential benefit? Human Reproduction 30(1): 3–8.
Article CAS PubMed Google Scholar
Armstrong, S., M. Atkinson, J. MacKenzie, A. Pacey, and C. Farquhar. 2019. Add-ons in the laboratory: Hopeful, but not always helpful. Fertility and Sterility 112(6): 994–999.
Asplund, K. 2020. Use of in vitro fertilization—ethical issues. Upsala Journal of Medical Sciences 125(2): 192–199.
Attinger, S., E. Jackson, I. Karpin, et al. 2024. Addressing the consequences of the corporatization of reproductive medicine. Medical Law Review. 32(4): 444–467.
Article PubMed PubMed Central Google Scholar
Bahadur, G., R. Homburg, and A. Al-Habib. 2017. A new dawn for intrauterine insemination: Efficient and prudent practice will benefit patients, the fertility industry and the healthcare bodies. Journal of Obstetrics and Gynecology of India 67(2): 79–85.
Bahadur, G., R. Homburg, A. Muneer, et al. 2016. First line fertility treatment strategies regarding IUI and IVF require clinical evidence. Human Reproduction 31(6): 1141–1146.
Article CAS PubMed Google Scholar
Bahadur, G., and R. Homburg. 2019. Growing body of evidence supports intrauterine insemination as first line treatment and rejects unfounded concerns about its efficacy, risks and cost effectiveness. JBRA Assisted Reproduction 23(1): 62–67.
PubMed PubMed Central Google Scholar
Bahadur, G., R. Homburg, A. Muneer, et al. 2022. Global inequality in sub-fertility treatment needs safer, cost effective, evidence-based and economically viable choices for patients and stakeholders. JBRA Assisted Reproduction 26(1): 1–2.
Article PubMed PubMed Central Google Scholar
Balen, A., L. Regan, S. Avery, et al. 2017. Rapid response: Lack of evidence for interventions offered in UK fertility centres. BMJ, January 18. http://www.bmj.com/content/355/bmj.i6295/rr-3. Accessed 20 May 2024.
Barat, S. 2023. Ethical and marketing perspectives on surrogacy tourism. Ethics and Bioethics 13(1-2): 28–37.
Barbey, C. 2017. Evidence of biased advertising in the case of social egg freezing. New Bioethics 23(3): 195–209.
Barnreuther, S. 2020. Traders of gametes, brokers of values: Mediating commercial gamete donations in Delhi. Economy and Society 49(3): 455–473.
Bayefsky, M.J., and L. King. 2019. Ethical and legal analysis of advertising for planned oocyte cryopreservation. Fertility and Sterility 112(3): E51.
Beilby, K., I. Dudink, D. Kablar, M. Kaynak, S. Rodrigo, and K. Hammarberg. 2020. The quality of information about elective oocyte cryopreservation (EOC) on Australian fertility clinic websites. The Australian and New Zealand Journal of Obstetrics and Gynaecology 60(4): 605–609.
Ben Rafael, Z. 2020. Repeated implantation failure (RIF): An iatrogenic meaningless definition that generates unnecessary and costly use of add-on procedures. Human Reproduction 35(7):1479–1483.
Bhardwaj, R. 2020. Reinterpreting epistemologies: An exploratory study of the ova donation websites in Delhi. Social Theory & Health 19: 331–346.
Bhatia, N, and L. Porceddu. 2021. Emptying the nest egg to fill the nursery: Early release of superannuation to fund assisted reproductive technology. UNSW Law Journal 44 (2): 513–547.
Bhide, P., A. Maheshwari, R. Cutting, et al. 2017. Time lapse imaging: Is it time to incorporate this technology into routine clinical practice? Human Fertility 20(2): 74–79.
Blake, V.K., M.L. McGowan, and A.D. Levine. 2015. Conflicts of interest and effective oversight of assisted reproduction using donated oocytes. Journal of Law, Medicine & Ethics 43(2): 410–424.
Blakely, B., J. Williams, C. Mayes, I. Kerridge, and W. Lipworth. 2017. Conflicts of interest in Australia’s IVF industry: An empirical analysis and call for action. Human Fertility 22(4): 230–237.
Bokek-Cohen, Y., and L. Gonen. 2015. Sperm and simulacra: Emotional capitalism and sperm donation industry. New Genetics and Society 34(3): 243–273.
Borsa, A., G. Bejarano, M. Ellen, and J. Bruch. 2023. Evaluating trends in private equity ownership and impacts on health outcomes, costs, and quality: Systematic review. BMJ 382: e075244.
Article PubMed PubMed Central Google Scholar
Braakhekke, M., I. Scholten, F. Mol, J. Limpens, B.W. Mol, ands F. van der veen. 2017. Selective outcome reporting and sponsorship in randomized controlled trials in IVF and ICSI. Human Reproduction 32(1): 2117–2122.
Article CAS PubMed Google Scholar
Braga, D., A.S. Setti, and E. Borges. 2022. Ethics and IVF add-ons: “We need to talk about it.” JBRA Assisted Reproduction 26(3): 371–373.
Article PubMed PubMed Central Google Scholar
Brezis, M., A. Malkiel, D. Chinitz, and L.S. Lehmann. 2011. Discordant views of experts and laypersons on the adoption of new fertility technology. Medical Care 49(4): 420–423.
European IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE), C. Calhaz-Jorge, J. Smeenk, C. Wyns, et al. 2024. Survey on ART and IUI: Legislation, regulation, funding and registries in European countries–an update. Human Reproduction 39(9): 1909–1924
Calik, K.Y., and H.K. Bulut. 2020. Assessment of Turkey IVF (in vitro fertilization) websites according to the American Society for Reproductive Medicine (ASRM)/Society for Assisted Reproductive Technology (SART) guidelines. Journal of the Pakistan Medical Association 70(3): 421–426.
Carbone, J., and N. Cahn. 2015. Commentary. Journal of the Law and the Biosciences 2(1): 105–111.
Carbone, J., and Madeira, J. 2016. Buyers in the baby market: Towards a transparent consumerism. Washington Law Review 91(1): 71–108.
Cattapan, A. 2014. Risky business: Surrogacy, egg donation and the politics of exploitation. Canadian Journal of Law and Society 29 (3): 361–379.
Chakravarthi, I. 2016. Regulation of assisted reproductive technologies: Gains and losses. Indian Journal of Gender Studies 23(1): 133–156.
Chambers, G.M., E.A. Sullivan, O. Ishihara, M.G. Chapman, and G.D. Adamson. 2009. The economic impact of assisted reproductive technology: A review of selected developed countries. Fertility and Sterility 91(6): 2281–2294.
Comments (0)